Kaitlyn D’Onofrio

DocwireNews

Even if negative margins cannot be achieved in patients with adenoid cystic carcinoma (ACC) of the trachea, outcomes may not differ, with or without adjuvant radiation, according to recent research.&ldquo;Performing a complete resection of tracheal adenoid cystic carcinoma and achieving negative surgical margins can be difficult,&rdquo; said study author Chi-fu Jeffrey Yang, MD, of Duke University Medical Center in Durham, N.C., in a presentation. &ldquo;Patients are often not diagnosed until they develop relatively bulky, locally advanced tumors, because their only symptoms are uncommon.&rdquo;Yang presented the study&rsquo;s findings at the 65th Annual Meeting &amp; Exhibition of the Southern Thoracic Surgeons Association.&ldquo;Aggressively chasing negative microscopic margins can lead to excessive longitudinal tracheal resection that could preclude safe reconstruction,&rdquo; Yang said.Yang noted that the impact of microscopic positive margins on long-term outcomes has not been well characterized. Long-term local control has been reported after resection, even with positive surgical margins. Radiation has tended to be recommended to be given after resection for adenoid cystic carcinoma; however, evidence supporting the benefit of postoperative radiation for adenoid cystic carcinoma in terms of either local control or long-term survival is scant.&ldquo;There is limited literature regarding the management of tracheal adenoid cystic carcinoma, probably because it is a rare tumor and because there are few centers that regularly perform tracheal resections,&rdquo; Yang noted.Yang and his team therefore sought to find evidence supporting treatment strategies for tracheal ACC. They hypothesized that positive margins following ACC resection would be associated with worse survival and that postoperative adjuvant radiation would improve survival rates. They used the National Cancer Data Base to collect information on tracheal ACC resection patients from 1998 through 2015 whose margin status they could determine. Patients were excluded if they had nodal or distant disease. Eligible patients were evaluated using Kaplan-Meier and Cox proportional hazard analysis.According to the abstract, 152 patients met inclusion criteria, of which 87 (57%) had postresection positive margins. Characteristics including age, female sex, race, tumor size, and year of diagnosis did not differ greatly between the groups, Yang said. Negative margin patients had lower T status at baseline than positive margin patients (T1, 35.1% vs 12.3%; T2, 40.5% vs 35.1%; T3, 10.8% vs 15.8%; T4, 13.5% vs 30.3%). Negative margin patients were also less likely to undergo adjuvant radiation therapy (62.3% vs 78.5%, P = 0.04).Adjuvant radiation was administered to 105 (69%) of the total cohort and 66 (76%) of the positive margin patients, according to the study abstract. Patients with elevated T status were more likely to have positive margins (T4 compared to T1 adjusted odds ratio [OR], 6.31; 95% CI: 1.76-22.67; P = 0.005). Patients with positive margins and negative margins did not have significantly different five-year survival rates (80% [95% CI: 69-87] vs 84% [95% CI: 70-91], P = 0.49), even after multivariable adjustment (hazard ratio [HR], 2.24; 95% CI: 0.84-6.02; P = 0.11). Analysis of the positive margin group showed no significant difference in five-year survival between patients who received postoperative adjuvant radiation therapy and those who did not (80% [95% CI: 67-88] vs 80% [95% CI: 55-92], P = 0.71), even after multivariable adjustment (HR, 0.54; 95% CI: 0.13-2.18; P = 0.39).Perioperative outcomes differed slightly between the positive margins and negative margins groups, Yang said, with the exception of hospital stay, which was seven days for both cohorts. Positive margins patients had higher 30-day and 90-day mortality rates (30-day, 2.5% vs 0.0%; P = 0.24; 90-day, 6.3% vs 0.0%; P = 0.11). However, 30-day readmission rates were lower in the positive margins group (1.3% vs 3.8%, P = 0.40).The study authors concluded in their abstract that while adjuvant radiation therapy is often used in patients with positive margins, it does not benefit survival rates.

Jordana Jampel

Mechanism of Positive Association Between Parkinson’s Disease and Melanoma Revealed in New Research

Melanoma

Hatem Soliman, MD

Using Dendritic Cell Vaccines to Boost Neoadjuvant Therapy in HER2+ Breast Cancer

HER2 Breast Cancer

Kathleen Liu, MD

Joel M. Topf, MD, FACP

AKI Approaches and ASN Kidney Health Guidance

NKF Spring Clinical Meetings 2025

Latest News

Study: Positive Margins Do Not Impact Survival Outcomes in Tracheal Adenoid Cystic Carcinoma Resection

STSA 2018

Even if negative margins cannot be achieved in patients with adenoid cystic carcinoma (ACC) of the trachea, outcomes may not differ, with or without adjuvant radiation, ...

Study: Positive Margins Do Not Impact Survival Outcomes in Tracheal Adenoid Cystic Carcinoma

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe